Today’s NY Times included a high profile article about the difficult balance between the clinical value of some expensive cancer therapies and their financial value. I think it did a fair job of portraying both sides of the issue — that therapies like avastin, erbitux, and others are certainly priced aggressively […]
14 CommentsThe National Coalition for Cancer Survivorship (NCCS) is the oldest survivor-led advocacy group, and they recently released some highlights of their study on perceptions of chemotherapy vs. the experience of patients who actually underwent chemotherapy for a cancer in the last few years. Because several membes have raised questions of whether […]
12 Comments
Posts
| Core Concepts
| Subject Archives
| Monthly Archives
| Resources
|
Donate
| Forums
| GRACE Home
Disclaimer: The information provided at GRACE is for informational purposes only. The faculty of GRACE is not providing medical advice, diagnosis or treatment and cannot replace the medical advice of your doctor or health care provider. (Full Disclaimer)
© 2007-2008 GRACE. All rights reserved.
